[13] These bouts are typically observed in the mating season
Under the UK Patient Group Directions for Wegovy and Mounjaro , continued treatment for weight management is only permitted while: BMI remains at or above 22 kg/m This applies: To maintenance treatment To all ethnicities Regardless of dose strength Once BMI falls below 22 kg/m , GLP-1 medication must usually be stopped
We look not only at weight loss, but also at lifestyle, nutrition and how to maintain the results achieved, even after tapering off or stopping
Get medical help right away if you have: A rash over your whole body Trouble breathing A fast heartbeat Sweating Swelling of your face, tongue, or throat Shortness of breath Extreme drowsiness, dizziness, or confusion Other possible side effects may include swelling, weight gain, low potassium levels, injection site reactions, including changes in fat tissue at the injection site, and allergic reactions